SCHEMBL5480930

SCHEMBL5480930

O=C(Nc1cccc(-c2cn3ccnc3c(-n3ccnc3-c3ccccc3)n2)c1)c1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.59
SYK P43405 1/20 0.55
KDM4E B2RXH2 3/20 0.53
LMNA P02545 3/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.53
GAA P10253 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
EPHB4 P54760 8/20 0.53
POLB P06746 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GFER P55789 1/20 0.52
MAPK1 P28482 2/20 0.52
MEN1 O00255 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477799 0.94 BTK (0.61) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5481231 0.91 BTK (0.59) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5479930 0.88 TP53 (0.56) KDM4ELMNAALDH1A1MAPTEPHB4
SCHEMBL5482708 0.86 BTK (0.54) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5482107 0.85 POLB (0.56) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5482638 0.85 EPHB4 (0.56) KDM4ELMNAALDH1A1MAPTEPHB4
SCHEMBL5479920 0.85 HIF1A (0.52) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5477850 0.85 SYK (0.56) BTKSYKKDM4EALDH1A1MAPT
SCHEMBL5483360 0.85 AURKA (0.56) BTKSYKKDM4ELMNAALDH1A1
SCHEMBL5478329 0.84 EPHB4 (0.56) KDM4EALDH1A1MAPTEPHB4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7160885-B2 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity CGI PHARMACEUTICALS, INC. (US) 2007-01-09 US claimed
US-20050054649-A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-A]pyrazines as modulators of Hsp90 complex activity XEROX CORPORATION 2005-03-10 US claimed
US-7160885-B2 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity CGI PHARMACEUTICALS, INC. (US) 2007-01-09 US disclosed
US-7160885-B2 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity CGI PHARMACEUTICALS, INC. (US) 2007-01-09 US disclosed
US-7160885-B2 Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity CGI PHARMACEUTICALS, INC. (US) 2007-01-09 US disclosed
US-20050054649-A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-A]pyrazines as modulators of Hsp90 complex activity XEROX CORPORATION 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054649-A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-A]pyrazines as modulators of Hsp90 complex activity HSP90AB1, HSP90AA1, HSPA9 BTK 380/4885SYK 778/4885KDM4E 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.